Упрощенная HTML-версия
163
105.Miller E.J. Elevated levels of NAP-L/ interleukin-8 are present in the airpac-
es of patients with the adult respiratory distress syndrome and are associat-
ed with increased mortality / E.J. Miller, A.B. Cohen, S. Nagao, et al. //
Am. Rev. of Respir. Dis. – 1992. – Vol. 146. – p. 427-432.
106.Mosconi P. Epidemiology and risk factors of pneumonia in critically ill pa-
tients. Intensive Care Unit Droup for Infection Control / P. Mosconi, M.
Langer, M. Cigada, M. Mandelli // Eur. J. Epidemiol. – 1992. – Vol. 7. – p.
320-327.
107.Nelson S. Novel nonantibioti c therapies for pneumonia – cytokines and host
defense / S. Nelson // Chest. – 2001. – Vol. 119. – p. 419-425.
108.Niederman M.S. Bronchoscopy for pneumonia: indications, methodology
and clinical application / M.S. Niederman, A. Torres. – Textbook of bron-
choscopy. Williams and Wilkins. – 1995; pp. 221-241.
109. Orozco-Levi M. Semirecumbent position protects from pulmonary aspira-
tion but not completely from gastroesophageal reflux in mechanically ven-
tilated patients / M.Orozco-Levi, A. Torres, M. Ferrer, C. Piera, M. el-
Ebiary, J.P. de la Bellacasa // Am. Respir. Crit. Care Med. - 1995. - Vol.
152. - p. 1387-1390.
110.Osmon S. Hospital mortality for patients with bacteremia due to Staphylo-
coccus aureus or Pseudomonas aeruginosa / S. Osmon, S. Ward, V. Fraser
// Chest. – 2004. – Vol. 125. – p. 607-616.
111.Ost D.E. Decision analysis of antibiotic and diagnostic strategies in ventila-
tor – associated pneumonia // Am. J. Respir. Crit. Care Med. – 2003. – Vol.
168 (9). – p. 1060-1067.
112.Pingleton S.K. Patient selection for clinical investigation of ventilator-
associated pneumonia: criteria for evaluating diagnostic techniques / S.K.
Pingleton, J.Y. Fagon, et al. // Chest. – 1995. – Vol. 102. – p. 553-556.